As of May 27
| +0.63 / +1.22%|
The 3 analysts offering 12-month price forecasts for ANI Pharmaceuticals Inc have a median target of 55.00, with a high estimate of 55.00 and a low estimate of 49.00. The median estimate represents a +5.20% increase from the last price of 52.28.
The current consensus among 3 polled investment analysts is to Buy stock in ANI Pharmaceuticals Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.